Skip to content

Safety, Tolerability and Efficacy Evaluation of Cold Relief Roll-on

Safety, Tolerability and Efficacy Evaluation of Cold Relief Roll-on in Improving Symptoms of Cold in Infants and Young Children - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/105404
Enrollment
60
Registered
2026-03-05
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J00- Acute nasopharyngitis [common cold]

Interventions

None listed

Sponsors

Mother Sparsh Baby Care Pvt. Ltd.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects between the ages 3 months to 12 years of either sex. 2. Subjects with acute cold symptoms with nasal and/or chest congestion present for less than or equal to 48 hours. 3. Subjects with at least mild-moderate nasal or chest congestion. 4. Mothers or guardians who agrees to participate their child in this trial and signs a written consent form before the test begins.

Exclusion criteria

Exclusion criteria: 1. Subject with severe systemic illness, fever unstable chronic conditions, immunodeficiency, birth defects, anomalies, or other serious comorbidities that could interfere with study participation or safety. 2. Subjects with known allergy or hypersensitivity to any ingredient in the study product, or a history of asthma triggered by topical aromatic products. 3. Subjects with skin conditions at application site, open wounds, eczema flare, rash, burns, or infection that may interfere with topical application or assessments. 4. Subjects using prohibited medications (topical or systemic decongestants, corticosteroids, antihistamines, or other cold medications) within 24-48 hours prior to enrolment. or those judged by the investigator to be inappropriate for participation in the trial.

Design outcomes

Primary

MeasureTime frame
Mean change in the severity scores for cold clinical symptoms.Timepoint: Day 1, Day 4, Day 8, Day 10

Secondary

MeasureTime frame
Mean change in the cough severity by parent-reported cough or congestion diary.Timepoint: Day 1, Day 4, Day 8, Day 10;Mean change in the sleep quality score by parent-reported outcomes.Timepoint: Day 1, Day 4, Day 8, Day 10

Countries

India

Contacts

Public ContactJestin V Thomas

Leads Clinical Research and Bio Services Pvt. Ltd.

jestin.leadsclinbio@gmail.com9845125293

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026